Paul Cătălin Toboltoc

Mr. Paul Cătălin Toboltoc


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CȘCristina M. Șulea
Cristina M. Șulea
VNValentin Nadasan
Valentin Nadasan
TUTatiana Ursachi
Tatiana Ursachi
PTPaul Cătălin Toboltoc
Paul Cătălin Toboltoc
Theodora BenedekTheodora Benedek
Theodora Benedek
Background: The internet provides general users with wide access to medical information. However, regulating and controlling the quality and reliability of the considerable volume of available data is challenging, thus generating concerns about the consequences of inaccurate health care–related documentation. Several tools have been proposed to increase the transparency and overall trustworthiness of medical information present on the web. Objective: We aimed to analyze and compare the quality and reliability of information about percutaneous coronary intervention on English, German, Hungarian, Romanian, and Russian language websites. Methods: Following a rigorous protocol, 125 websites were selected, 25 for each language sub-sample. The websites were assessed concerning their general characteristics, compliance with a set of eEurope 2002 credibility criteria, and quality of the informational content (namely completeness and accuracy), based on a topic-specific benchmark. Completeness and accuracy were graded independently by 2 evaluators. Scores were reported on a scale from 0 to 10. The 5 language subsamples were compared regarding credibility, completeness, and accuracy. Correlations between credibility scores on the one hand, and completeness and accuracy scores, on the other hand, were tested within each language subsample. Results: The websites’ compliance with credibility criteria was average at best with scores between 3.0 and 6.0. In terms of completeness and accuracy, the website subsets qualified as poor or average, with scores ranging from 2.4 to 4.6 and 3.6 to 5.3, respectively. English language websites scored significantly higher in all 3 aspects, followed by German and Hungarian language websites. Only German language websites showed a significant correlation between credibility and information quality. Conclusions: The quality of websites in English, German, Hungarian, Romanian, and Russian languages about percutaneous coronary intervention was rather inadequate and may raise concerns regarding their impact on informed decision-making. Using credibility criteria as indicators of information quality may not be warranted, as credibility scores were only exceptionally correlated with content quality. The study brings valuable descriptive data on the quality of web-based information regarding percutaneous coronary intervention in multiple languages and raises awareness about the need for responsible use of health-related web resources.

26 November 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
RCRoxana Mihaela Crișan
Roxana Mihaela Crișan
CBCIPRIAN BACILA
CIPRIAN BACILA
PTPaul Cătălin Toboltoc
Paul Cătălin Toboltoc
SMSilviu Morar
Silviu Morar
The COVID-19 pandemic is associated with suicide, as some data suggests. Our study aims to investigate the emergence of eleven completed suicide cases suspected to be linked to the COVID-19 pandemic during the restrictive measures imposed by the Romanian government, and to identify the consequences of mental health, suicidal motivation, and behavioral changes. To this end, we analyzed the deceased’s medical records and applied the psychological autopsy method to the relatives/caregivers of the deceased for a suicidal investigation history, within conducted free-flow discussions. To highlight behavioral changes that occurred in the distant antecedents as well as immediately before the suicidal act, we used two sets of closed questions comprised of fifteen alarm signs, including depressive and/or anxiety symptoms. Our results showed that a deterioration of the mental status, especially concerning depressive and anxiety symptoms, was evident in people without or with pre-existing psychiatric pathology. The suicidal motivation proved to be complex including, in addition to the SARS-CoV-2 infection, social and economic consequences of the COVID-19 pandemic. We noted an intensification of the investigated alarm signs and even the emergence of new warning signs in the recent antecedents. Based on our findings, we reaffirmed the important role of the psychological autopsy method in suicide investigation, proving that it can detect the specific impact of the COVID-19 pandemic on people prone to suicide. This impact can be psycho-emotional, social, and/or economical, and thus we can state that the COVID-19 pandemic and its consequences can be, at least, a triggering factor that enhances completed suicide risk. Further studies are needed in this particular area because correlations between the COVID-19 pandemic and completed suicide do not appear to be accidental.

21 May 2026 in Cureus
Verified
Journal Article
Open access
PTPaul Cătălin Toboltoc
Paul Cătălin Toboltoc
AVAdela Vekony
Adela Vekony
GIGagiu Ioana
Gagiu Ioana
Background B-cell non-Hodgkin lymphoma (B-NHL) requires timely tissue diagnosis, staging, and therapeutic planning, the clinical trajectory being shaped from the outset by stage at presentation, tumor burden, symptom burden, and organ involvement; against that background, pandemic-related disruption of non-COVID services raised concern that patients with hematologic malignancies might re-enter care later and in less favorable clinical condition. This study evaluated whether the post-pandemic recovery in case numbers at a Romanian tertiary center was accompanied by a shift toward more advanced and more symptomatic disease at diagnosis. Methods This retrospective single-center study included adults newly diagnosed with B-NHL at the Sibiu County Emergency Clinical Hospital between March 11, 2018, and March 7, 2024. The cohort was stratified into pre-pandemic, pandemic, and post-restriction intervals to capture the clinical consequences of successive healthcare contexts. Patients were eligible if they had at least two standard inpatient admissions within the corresponding period, day-hospital admissions being excluded, and records that were incomplete, inconsistent, or clearly erroneous also being removed. Demographic, clinicopathologic, treatment-related, and selected laboratory variables were analyzed. Results Of 585 lymphoma records initially identified, 366 met the general eligibility criteria, and 123 met the study-specific criteria for newly diagnosed B-NHL, including 43 pre-pandemic cases, 35 pandemic cases, and 45 post-restriction cases. Although the histopathologic spectrum remained broadly stable, diffuse large B-cell lymphoma continuing to predominate throughout, the post-restriction interval was marked by a redistribution toward more advanced disease, with advanced stage III-IV cases increasing from 25 patients before the pandemic and 21 during the pandemic to 34 after restrictions, while stage IV disease increased from 16 and 13 cases in the first two intervals to 22 cases in the post-restriction interval. Additionally, the proportion of patients without B-symptoms fell from 53.5% and 62.9% in the first two intervals to 11.1% thereafter. Conclusions In this cohort, the numerical recovery in newly diagnosed B-NHL cases after the pandemic was accompanied not by full clinical normalization, but by a more advanced and more symptomatic pattern of presentation, the overall findings being compatible with delayed access to timely lymphoma evaluation and with the persistence of downstream effects even after formal service reopening.

19 July 2022 in JMIR Preprints
Verified
Preprint
Open access
CȘCristina M. Șulea
Cristina M. Șulea
VNValentin Nadasan
Valentin Nadasan
TUTatiana Ursachi
Tatiana Ursachi
PTPaul Cătălin Toboltoc
Paul Cătălin Toboltoc
Theodora BenedekTheodora Benedek
Theodora Benedek
BACKGROUND The Internet provides general users with wide access to medical information. However, regulating and controlling the quality and reliability of the immense volume of available data is challenging, therefore generating concerns about the consequences of inaccurate healthcare-related documentation. Several tools have been proposed in an effort to increase the transparency and overall trustworthiness of medical information present online. OBJECTIVE To analyze and compare the quality and reliability of information about percutaneous coronary intervention on English, German, Hungarian, Romanian, and Russian language websites. METHODS Following a rigorous protocol, 125 websites were selected, 25 for each language subsample. The websites were assessed concerning their general characteristics, compliance with a set of eEurope 2002 credibility criteria, and quality of the informational content (namely completeness and accuracy), based on a topic-specific benchmark. Completeness and accuracy were graded independently by two evaluators. Scores were reported on a scale from 0 to 10. The five language subsamples were compared regarding credibility, completeness, and accuracy. Correlations between credibility scores on the one hand, and completeness and accuracy scores, on the other hand, were tested within each language subsample. RESULTS The websites’ compliance with credibility criteria was average at best with scores between 3.0 and 6.0. In matters of completeness and accuracy, the website subsets qualified as poor or average, with scores ranging from 2.4 to 4.6 and 3.6 to 5.3, respectively. English language websites scored significantly higher in all three aspects, followed by German and Hungarian language websites. Only German language websites showed a significant correlation between credibility and completeness. CONCLUSIONS The quality of websites in English, German, Hungarian, Romanian, and Russian language about percutaneous coronary intervention was rather inadequate and may raise concerns regarding their impact on informed decision-making. Using credibility criteria as indicators of information quality may not be warranted as credibility scores were only exceptionally correlated with content quality.

8 September 2026 in Romanian Journal of Morphology and Embryology
Verified
Journal Article
Closed access
PTPaul Cătălin Toboltoc
Paul Cătălin Toboltoc
AVAdela Vekony
Adela Vekony
IGIoana Gagiu
Ioana Gagiu
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related immune dysregulation has generated interest in diagnostic pathology because infection-related inflammation, long coronavirus disease (COVID)-related immune disturbance, and post-vaccination lymphoid reactions may overlap with lymphoid-biological mechanisms and complicate the distinction between reactive lymphoid proliferations and lymphoid neoplasia. Aim: This scoping review aimed to map biologically plausible pathways through which SARS-CoV-2-associated immune perturbation may intersect with lymphomagenesis-related mechanisms, emphasizing diagnostic implications rather than causality. Materials and Methods: This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). PubMed/MEDLINE, Scopus, and Web of Science were searched from January 2020 to March 2026, with selected pre-2020 sources retained for mechanistic or diagnostic relevance. Sources were charted across mechanistic, immunological, virological, clinicopathological, and diagnostic domains. Results: After screening and eligibility assessment, 63 sources were retained for thematic synthesis. Evidence clustered around lymphoma-relevant but non-specific mechanisms, including inflammatory signaling, impaired immune surveillance, latent oncogenic viral reactivation, prolonged germinal-center activity with activation-induced cytidine deaminase (AID)-related genomic vulnerability, and lymphoid microenvironment remodeling. These mechanisms appear most relevant in predisposed hosts with chronic immune dysregulation, latent viral infection, defective deoxyribonucleic acid (DNA) repair, or occult abnormal lymphoid clones. Infection and vaccination are distinct contexts, because infection may produce broader immune disruption, whereas most post-vaccination nodal events are reactive and self-limited. Conclusions: Current evidence supports biological plausibility rather than a direct or generalizable causal relationship. The main diagnostic implication is careful clinicopathological correlation and distinction between reactive lymphoid proliferations and lymphoid neoplasia in post-COVID-19 and post-vaccination settings.

22 June 2026 in Cureus
Verified
Journal Article
Open access
PTPaul Cătălin Toboltoc
Paul Cătălin Toboltoc
IGIoana Gagiu
Ioana Gagiu
ALAlex L Lukusa
Alex L Lukusa
AVAdela Vekony
Adela Vekony
The COVID-19 pandemic disrupted cancer care at every level of the clinical pathway, but its effect on hemato-oncology was distinctive because patients with hematologic malignancies often require urgent diagnosis, frequent hospital visits, transfusion support, intensive therapy, transplantation, cellular therapy, and infection-sensitive follow-up. This narrative review examines the pandemic as a disruption of hemato-oncology care delivery rather than only as a source of excess infection-related morbidity. It synthesizes evidence on diagnostic access, patient flow, treatment prioritization, infection-control circuits, day-hospital organization, inpatient access, telemedicine and hybrid follow-up, supportive care, vaccination, antiviral pathways, and high-complexity care delivery. The review distinguishes between temporary crisis restrictions, harmful diagnostic and therapeutic delays, and durable organizational adaptations that may remain relevant after the acute pandemic period. Evidence from cancer-service disruption studies, hemato-oncology outcome registries, telemedicine cohorts, and European hematopoietic cell transplantation activity surveys indicates that hemato-oncology care pathways were reorganized and selectively redirected during the pandemic, while selected components recovered through structured triage, protected circuits, remote review of stable patients, and individualized timing of transplantation and cellular therapy. The post-pandemic priority is not to preserve restrictive crisis practice, but to retain the organizational discipline generated by the crisis: protected diagnostic capacity, risk-stratified access, selective hybrid care, rapid infectious-risk assessment pathways, disciplined day-hospital scheduling, and reserved in-person capacity for unstable, procedure-dependent, or curative-intent patients. These adaptations should be maintained only insofar as they improve access, safety, and continuity of care without normalizing delayed diagnosis or undertreatment of aggressive disease.